Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment
Stopped This study was terminated based on a business decision by the Sponsor.
Conditions
Interventions
- DRUG: GWP42003-P
- DRUG: Placebo
Sponsor
Jazz Pharmaceuticals